CapsoVision

CapsoVision Financial Leverage

The Financial Leverage (Equity Multiplier) of CapsoVision (CV) as of Oct 19, 2026 is 1.37. In the previous year, Financial Leverage (Equity Multiplier) was -0.13 — a change of -1,155.81% (higher).

Financial Leverage

1.37

YoY

-1,155.81%

Last updated:

Financial Leverage (Equity Multiplier) of CapsoVision is 2025 1.37 . Financial Leverage (Equity Multiplier) of CapsoVision was 2024 -0.13 . It decreases by -1,155.81% higher compared to the previous year.

The CapsoVision Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2023
-0.20 USD
Jan 1, 2024
-0.13 USD
Jan 1, 2025
1.37 USD
The CapsoVision Financial Leverage history
YEARFinancial LeverageYoY
1.37-1,155.81%
-0.13-33.80%
-0.20—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CapsoVision Stock analysis

What does CapsoVision do? CapsoVision Inc is a health care company based in Saratoga, California, operating within the health care sector. The company has 99 employees and is scheduled to go public with an IPO on July 2, 2025. CapsoVision develops medical technology products, including a small bowel capsule endoscope called CapsoCam Plus. This device utilizes a 360 panoramic lateral view to provide more comprehensive imaging compared to traditional end-facing cameras. The product is designed to be wire-free, enhancing patient comfort and convenience. The company also offers CapsoCloud, a cloud-based software application for secure and convenient clinical data management. Additionally, CapsoVision provides a capsule collection kit, a single-use, sanitary kit for patients to collect, store, and transport the CapsoCam Plus capsule. The company's website is https://www.capsovision.com/. CapsoVision Inc is focused on advancing medical technology solutions for gastrointestinal diagnostics, with a particular emphasis on improving patient experience through innovative design and secure data handling. CapsoVision is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CapsoVision stock

Financial Leverage (Equity Multiplier) of CapsoVision is 1.37 in 2025.

Financial Leverage (Equity Multiplier) of CapsoVision changed from -0.13 to 1.37, representing a -1,155.81% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) CapsoVision since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s CapsoVision with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — CapsoVision

All Key Metrics — CapsoVision